Device Trial Radar · NCT05883163
STIMIT Activator 1 IDE Study
Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Jan 24, 2024
Primary completion
Jan 2027
Study completion May 2027
Sponsor
- Lead sponsor
- Stimit AGNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 31, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is a prospective, multi-center, randomized, controlled study using adaptive design to assess the evidence of safety and performance of the STIMIT Activator 1 System in the treatment of patients who have been mechanically ventilated for up to 7 days and are predicted to require additional minimum 48 hours of mechanical ventilation or longer.
Conditions
- Diaphragm Issues
Interventions
Stimit Activator 1Device
The Stimit Activator 1 System will be used to stimulate the phrenic nerve resulting in diaphragm activation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efffectiveness: Preservation of Diaphragm ThicknessTime frame: Up to Day 10
- Safety: Rate of device or procedure related serious adverse events (SAEs)Time frame: Up to Day 10
Locations
4 sites in 2 countries. Site status is shown where the registry gives one.
Yale New Haven Hospital
New Haven, Connecticut · Recruiting
Beth Israel Deaconess Medical Center
Boston, Massachusetts · Recruiting
University of Virginia Medical Center
Charlottesville, Virginia · Completed
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.